Zhian Kang

Title: Innovations by Zhian Kang in Integrin-Blocking Polypeptides

Introduction

Zhian Kang is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of integrin-blocking polypeptides. With a total of two patents to his name, his work focuses on innovative solutions for treating solid tumors and rheumatoid arthritis.

Latest Patents

Zhian Kang's latest patents revolve around a series of integrin blockers that exhibit strong angiogenesis inhibiting performance, high integrin affinity, and integrin-bonding capacity. These integrin blockers, specifically polypeptide I, polypeptide II, and polypeptide III, are designed for the treatment of solid tumors and rheumatoid arthritis. The invention also encompasses the application of these polypeptides in the preparation of anti-tumor drugs. The tumors targeted by this innovation include primary and secondary cancers originating from various organs, such as the brain, thyroid, esophagus, pancreas, lung, liver, stomach, breast, kidney, gallbladder, colon, rectum, ovary, cervix, uterus, prostate, bladder, and testicle, as well as melanoma and sarcomas.

Career Highlights

Zhian Kang has established himself as a prominent figure in the biotechnology sector. His research and inventions have the potential to significantly impact cancer treatment and improve patient outcomes. His dedication to innovation is evident in his work on integrin-blocking polypeptides.

Collaborations

Zhian Kang collaborates with talented individuals in his field, including Hanmei Xu and Chunyan Pu. These partnerships enhance the research and development process, leading to more effective solutions in biotechnology.

Conclusion

Zhian Kang's contributions to the field of biotechnology, particularly through his patents on integrin-blocking polypeptides, showcase his commitment to advancing medical treatments. His work holds promise for improving therapies for solid tumors and rheumatoid arthritis, making a significant impact in the medical community.